Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$78.27 - $151.29 $750,609 - $1.45 Million
-9,590 Closed
0 $0
Q1 2021

May 03, 2021

BUY
$94.25 - $132.81 $70,687 - $99,607
750 Added 8.48%
9,590 $956,000
Q4 2020

Feb 02, 2021

BUY
$102.03 - $184.62 $2,040 - $3,692
20 Added 0.23%
8,840 $1.09 Million
Q3 2020

Nov 04, 2020

BUY
$93.53 - $163.34 $11,223 - $19,600
120 Added 1.38%
8,820 $859,000
Q2 2020

Aug 07, 2020

BUY
$126.3 - $176.56 $1.1 Million - $1.54 Million
8,700 New
8,700 $1.36 Million

Others Institutions Holding RETA

About REATA PHARMACEUTICALS INC


  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Treasurer Of The State Of North Carolina Portfolio

Follow Treasurer Of The State Of North Carolina and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Treasurer Of The State Of North Carolina, based on Form 13F filings with the SEC.

News

Stay updated on Treasurer Of The State Of North Carolina with notifications on news.